ALMS

NASDAQ · Pharmaceuticals

Alumis Inc

Small-Cap Stocks Stocks Under $10 Pharmaceutical Stocks Healthcare Stocks

$6.03

+0.18 (+3.08%)

As of Nov 7, 1:35 AM ET ·

ALMS News3 articles

Alumis Stock Craters 59% on Failed Lupus Trial

Alumis shares dropped 59% after its key lupus trial failed to meet primary and secondary endpoints, erasing $1.67 billion in market value.

Alumis Stock Jumps 15.6% on Strong Analyst Support and Psoriasis Trial Results

Alumis shares jumped 15.55% on double average volume, driven by strong analyst support and late-stage psoriasis data. The company remains high-risk with no approved products.

Rare Hindenburg Omen Flashes Twice as Wall Street Divergence Widens

A rare market warning signal, the Hindenburg Omen, flashed twice on Wall Street as tech stocks surge while other sectors lag, despite the S&P 500 hitting a new high.